Search research articles
Contact Us
Filters
Showing results (51-60 of 292) with videos related to
Page
of 30
Sort By:
Inflammopharmacology
|
November 23, 2022
Benzodiazepines in Alzheimer's disease: beneficial or detrimental effects
Hayder M Al-Kuraishy, Ali I Al-Gareeb, Hebatallah M Saad, et al.
Journal of Advanced Pharmaceutical Technology & Research
|
October 20, 2018
Differential effect of metformin and/or glyburide on apelin serum levels in patients with type 2 diabetes mellitus: Concepts and clinical practice
Hayder M Al-Kuraishy, Ali I Al-Gareeb, Huda J Waheed, et al.
Inflammopharmacology
|
February 28, 2023
Long-term use of metformin and Alzheimer's disease: beneficial or detrimental effects
Hayder M Al-Kuraishy, Ali I Al-Gareeb, Hebatallah M Saad, et al.
Future Science OA
|
June 6, 2022
Vinpocetine is the forthcoming adjuvant agent in the management of COVID-19
Hayder M Al-Kuraishy, Ali I Al-Gareeb, Muyiwa Samuel Fageyinbo, et al.
Virology Journal
|
October 9, 2022
Pathophysiology of Post-COVID syndromes: a new perspective
Gaber El-Saber Batiha, Hayder M Al-Kuraishy, Ali I Al-Gareeb, et al.
Inflammopharmacology
|
June 19, 2023
The potential effect of metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM)
Hayder M Al-Kuraishy, Ali I Al-Gareeb, Hebatallah M Saad, et al.
JPMA. the Journal of the Pakistan Medical Association
|
October 12, 2019
Berberine attenuates olanzapine induced-metabolic syndrome
Marwa Salih Al-Naimi, Huda Abdulbaki Rasheed, Hayder M Al-Kuraishy, et al.
Inflammopharmacology
|
May 9, 2023
The potential therapeutic effect of statins in multiple sclerosis: beneficial or detrimental effects
Hayder M Al-Kuraishy, Ali I Al-Gareeb, Hebatallah M Saad, et al.
Molecular Biology Reports
|
May 8, 2023
Orexin pathway in Parkinson's disease: a review
Mohammed Alrouji, Hayder M Al-Kuraishy, Ali I Al-Gareeb, et al.
Viral Immunology
|
August 13, 2021
Levamisole Therapy in COVID-19
Hayder M Al-Kuraishy, Ali I Al-Gareeb, Luay Alkazmi, et al.
Page
of 30
Search research articles
Search
Showing results (51-60 of 292) with videos related to
Sort By:
Page
of 30
Inflammopharmacology
|
November 23, 2022
Benzodiazepines in Alzheimer's disease: beneficial or detrimental effects
Hayder M Al-Kuraishy, Ali I Al-Gareeb, Hebatallah M Saad, et al.
Journal of Advanced Pharmaceutical Technology & Research
|
October 20, 2018
Differential effect of metformin and/or glyburide on apelin serum levels in patients with type 2 diabetes mellitus: Concepts and clinical practice
Hayder M Al-Kuraishy, Ali I Al-Gareeb, Huda J Waheed, et al.
Inflammopharmacology
|
February 28, 2023
Long-term use of metformin and Alzheimer's disease: beneficial or detrimental effects
Hayder M Al-Kuraishy, Ali I Al-Gareeb, Hebatallah M Saad, et al.
Future Science OA
|
June 6, 2022
Vinpocetine is the forthcoming adjuvant agent in the management of COVID-19
Hayder M Al-Kuraishy, Ali I Al-Gareeb, Muyiwa Samuel Fageyinbo, et al.
Virology Journal
|
October 9, 2022
Pathophysiology of Post-COVID syndromes: a new perspective
Gaber El-Saber Batiha, Hayder M Al-Kuraishy, Ali I Al-Gareeb, et al.
Inflammopharmacology
|
June 19, 2023
The potential effect of metformin on fibroblast growth factor 21 in type 2 diabetes mellitus (T2DM)
Hayder M Al-Kuraishy, Ali I Al-Gareeb, Hebatallah M Saad, et al.
JPMA. the Journal of the Pakistan Medical Association
|
October 12, 2019
Berberine attenuates olanzapine induced-metabolic syndrome
Marwa Salih Al-Naimi, Huda Abdulbaki Rasheed, Hayder M Al-Kuraishy, et al.
Inflammopharmacology
|
May 9, 2023
The potential therapeutic effect of statins in multiple sclerosis: beneficial or detrimental effects
Hayder M Al-Kuraishy, Ali I Al-Gareeb, Hebatallah M Saad, et al.
Molecular Biology Reports
|
May 8, 2023
Orexin pathway in Parkinson's disease: a review
Mohammed Alrouji, Hayder M Al-Kuraishy, Ali I Al-Gareeb, et al.
Viral Immunology
|
August 13, 2021
Levamisole Therapy in COVID-19
Hayder M Al-Kuraishy, Ali I Al-Gareeb, Luay Alkazmi, et al.
Page
of 30